Lithium and skin: Dermatologic manifestations of lithium therapy

International Journal of Dermatology

Volumn 47, Issue 11, 2008, Pages 1101-1111

  Jafferany, Mohammad ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; CORTICOSTEROID; CYCLIC AMP; EMOLLIENT AGENT; INOSITOL; KERATOLYTIC AGENT; KETOCONAZOLE; LEUKOTRIENE; LITHIUM CARBONATE; LITHIUM GLUCONATE; MOOD STABILIZER; OMEGA 3 FATTY ACID; PLACEBO; PROSTAGLANDIN DERIVATIVE; RETINOIC ACID DERIVATIVE; SALICYLIC ACID; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE ISOFORM 2; SELENIUM; SHAMPOO; STEROID; SUCCINATE LITHIUM; TETRACYCLINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE;

ACNE; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ASTEATOTIC DERMATOSIS; BIPOLAR DISORDER; BULLOUS SKIN DISEASE; BURNING SENSATION; CELL PROLIFERATION; CHEILITIS; CLINICAL FEATURE; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; CONGENITAL ICHTHYOSIFORM ERYTHRODERMA; CONTACT STOMATITIS; DARIER DISEASE; DEPRESSION; DERMATITIS HERPETIFORMIS; DESQUAMATION; DRUG CONTRAINDICATION; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ERUPTION; DRUG HALF LIFE; DRUG POTENTIATION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECZEMA; ENDOCRINE DISEASE; EPIDERMIS CELL; ERYTHEMA; ERYTHRODERMA; EXFOLIATION SYNDROME; EXFOLIATIVE DERMATITIS; FOLLICULITIS; GASTROINTESTINAL SYMPTOM; GEOGRAPHIC TONGUE; HAILEY HAILEY DISEASE; HAIR DISEASE; HEMATOLOGIC DISEASE; HERPES ZOSTER; HUMAN; HYPERKERATOSIS; HYPERPLASIA; INFLAMMATORY VERRUCOUS HYPERPLASIA; LICHENOID STOMATITIS; LOTION; MACULOPAPULAR RASH; MENTAL STRESS; METALLIC TASTE; MUCOSAL DISEASE; MYXEDEMA; NAIL DISEASE; NEURODERMATITIS; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUTROPHILIA; ONYCHOMADESIS; ORAL MUCOSAL DISEASE; PALMOPLANTAR KERATODERMA; PAPILLOMATOSIS; PAPULAR RASH; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PERLECHE; PRURITUS; PSORIASIS; PSYCHOTHERAPY; PUSTULAR PSORIASIS; PUSTULOSIS PALMOPLANTARIS; REVIEW; SEBORRHEIC DERMATITIS; SEX DIFFERENCE; SIDE EFFECT; SKIN DISEASE; STOMATITIS; SUBCORNEAL PUSTULAR DERMATOSIS; SUPPURATIVE HIDRADENITIS; TASTE DISORDER; TINEA VERSICOLOR; TUMEFACTION; VERRUCA VULGARIS; VIRAL SKIN DISEASE; VIRUS INFECTION; XEROSIS; XEROSTOMIA;

ANTIMANIC AGENTS; HUMANS; LITHIUM COMPOUNDS; SKIN DISEASES; SKINFOLD THICKNESS;

EID: 55449106704     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.03873.x     Document Type: Review

References (160)

1. Price LH, Heninger GR. Lithium in the treatment of mood disorders. N Engl J Med 1994; 331: 591-598.
2. Cade JF. Lithium salts in the treatment of psychotic excitement. Med J Aust 1949; 36: 349-352.
3. Fieve RR, Platman SR, Plutchick RH. The use of lithium in affective disorders. I. Acute endogenous depression. Am J Psychiatry 1968; 125: 487-491.
4. Fieve RR, Platman SR, Plutchick RH. The use of lithium in affective disorders. II. Prophylaxis of depression in chronic recurrent affective disorder. Am J Psychiatry 1968; 125: 492-498.
5. Vestergaard P. Amdisen A, Schou M. Clinically significant side effects of lithium treatment: A survey of 237 patients in long term treatment. Acta Psychiatr Scand 1980; 62: 193-200.
6. Sarantidis D, Waters B. A review and controlled study of cutaneous conditions associated with lithium carbonate. Br J Psychiatry 1983; 143: 42-50.
7. Chan HH, Wing Y, Sue R, et al. A control study of the cutaneous side effects of chronic lithium therapy. J Affect Disord 2000; 57: 107-113.
8. Mork A, Geisler A, Hollund P. Effects of lithium on second messenger systems in the brain. Pharmacol Toxicol 1992; 71: 4-17.
9. Risby ED, Hsiao JK, Manji HK, et al. The mechanism of action of lithium. II. Effects on adenylate cyclase activity and β-adrenergic receptor binding in normal subjects. Arch Gen Psychiatry 1991; 48: 513-524.
10. Manji HK. G proteins: Implications for psychiatry. Am J Psychiatry 1992; 149: 746-760.
11. McGrath BM, Greenshaw AJ, McKay R, et al. Unlike lithium, anticonvulsants and antidepressants do not alter rat brain myoinositol. Neuroreport 2007; 18: 1595-1598.
12. Yanagita T, Maruta T, Uezono Y, et al. Lithium inhibits function of voltage-dependent sodium channels and catecholamine secretion independent of glycogen synthase kinase-3 in adrenal chromaffin cells. Neuropharmacology 2007; 53: 881-889.
13. Devaki R, Shankar Rao S, Nadgir SM. The effect of lithium on the adrenoceptor-mediated second messenger system in the rat brain. J Psychiatry Neurosci 2006; 31: 246-252.
14. Kast RE. How lithium treatment generates neutrophilia by enhancing phosphorylation of GSK-3, increasing HIF-1 levels and how this path is important during engraftment. Bone Marrow Transplant 2008; 41: 23-26.
15. Chuang DM, Manji HK. In search of the holy grail for the treatment of neurodegenerative disorders: Has a simple cation been overlooked? Biol Psychiatry 2007; 62: 4-6.
16. Howland RH. Lithium: Underappreciated and underused. J Psychosoc Nurs Ment Health Serv 2007; 45: 13-17.
17. DiGiovanna JJ, Aoyagi T, Taylor JR, et al. Inhibition of epidermal adenyl cyclase by lithium carbonate. J Invest Dermatol 1981; 76: 259-263.
18. Berridge MJ, Irvine RF. Inositol triphosphate, a novel second messenger in cellular signal transduction. Nature 1984; 312: 315-321.
19. Willmorth F, Spleiss O, Weismann K, et al. Expression of G-proteins and regulators of G-protein signalling in neutrophils of patients with bipolar disorder: Effects of mood stabilizers. Bipolar Disord 2002; 4(suppl. 1): 75-76.
20. + cells in lithium treated patients. Br J Haematol 1988; 100: 219-221.
21. Heng MCY. Cutaneous manifestations of lithium toxicity. Br J Dermatol 1982; 106: 107-109.
22. Jafferany M. Psychodermatology: A guide to understanding common psychocutaneous disorders. Prim Care Companion J Clin Psychiatry 2007; 9: 203-213.
23. Callaway CL, Hendrie HC, Luby ED. Cutaneous conditions observed in patients during treatment with lithium. Am J Psychiatry 1968; 124: 1124-1125.
24. Kusumi Y. A cutaneous side effect of lithium: Report of two cases. Dis Nerv Syst 1971; 32: 853-854.
25. Kanzaki T. Acneiform eruption induced by lithium carbonate. J Dermatol 1991; 18: 481-483.
26. Oztas P, Aksakal AB, Oztas MO. Severe acne with lithium. Ann Pharmacother 2001; 35: 961-962.
27. Heng MCY. Lithium carbonate toxicity: Acneiform eruption and other manifestations. Arch Dermatol 1982; 118: 246-248.
28. Rothstein G, Clarkson DR, Larsen W, et al. Effect of lithium on neutrophil mass and production. N Engl J Med 1978; 298: 178-180.
29. Zurier RB, Hoffstein S, Weissman G. Mechanisms of lysosomal enzyme release from human leukocytes. J Cell Biol 1973; 58: 27-41.
30. Reiffers J, Dick P. Cutaneous side effects of treatment with lithium. Dermatologica 1977; 155: 155-163.
31. Remmer HI, Falk WE. Successful treatment of lithium-induced acne. J Clin Psychiatry 1986; 47: 48.
32. Malt U. Lithium carbonate and tetracycline interaction [Letter]. Br Med J 1978; 2: 502.
33. Okrasinski H. Lithium acne. Dermatologica 1977; 154: 251-253.
34. Aldoroty N, LeVine WR. Dermatosis and lithium therapy. Am J Psychiatry 1980; 137: 870.
35. Deandrea D, Walker N, Mehlmauer M, et al. Dermatological reactions to lithium: A critical review of the literature. J Clin Psychopharmacol 1982; 2: 199-204.
36. Fry L, Baker BS. Triggering psoriasis: The role of infections and medications. Clin Dermatol 2007; 25: 606-615.
37. Tsankov N, Angelova I, Kazandjieva J. Drug-induced psoriasis: Recognition and management. Am J Clin Dermatol 2000; 1(3): 159-165.
38. Lowe NJ, Ridgway HB. Generalized pustular psoriasis precipitated by lithium carbonate. Arch Dermatol 1978; 114: 1788-1789.
39. Abel EA, DiCicco LM, Orenberg EK, et al. Drugs in exacerbation of psoriasis. J Am Acad Dermatol 1986; 15: 1007-1022.
40. Pande AC, Max P, Donnelly RF. Lithium associated with psoriasis. J Clin Psychiatry 1986; 47: 330.
41. Skerritt PW. Psoriatic arthritis during lithium therapy. Aust NZ J Psychiatry 1987; 21: 601-604.
42. Farber EM, Nall L. Pustular psoriasis. Cutis 1993; 5: 29-32.
43. White SW. Palmoplantar pustular psoriasis provoked by lithium therapy. J Am Acad Dermatol 1982; 7: 660-662.
44. Rudolph RI. Lithium induced psoriasis of the finger nails. J Am Acad Dermatol 1992; 26: 135-136.
45. Hooper JF. Lithium carbonate and toe nails. Am J Psychiatry 1981; 138: 1519.
46. Don PC, Silverman RA. Nail dystrophy induced by lithium carbonate. Cutis 1988; 41: 19-21.
47. Evans DL, Martin W. Lithium carbonate and psoriasis. Am J Psychiatry 1979; 136: 1326-1327.
48. Skoven I, Thormann J. Lithium compound treatment and psoriasis. Arch Dermatol 1979; 115: 1185-1187.
49. Bakker JB, Pepplinkhuizen L. More about the relationship of lithium to psoriasis. Psychosomatics 1976; 17: 143-146.
50. Carter TN. The relationship of lithium carbonate to psoriasis. Psychosomatics 1972; 13: 325-327.
51. O'Brien Koo J. The mechanism of lithium and beta-blocking agents in inducing and exacerbating psoriasis. J Drugs Dermatol 2006; 5: 426-432.
52. Hwang SM, Ahn SK, Menon GK, et al. Basis of occlusive therapy in psoriasis: Correcting defects in permeability barrier and calcium gradient. Int J Dermatol 2001; 40: 223-231.
53. Odagaki Y, Koyama Y, Yamashita I. Lithium and serotonergic neural transmission: A review of pharmacological and biochemical aspects in animal studies. Lithium 1992; 100: 3-12.
54. Hemlock C, Rosenthal JS, Winston A. Fluoxetine-induced psoriasis. Ann Pharmacother 1992; 26: 211-212.
55. Voorhees JJ, Marcelo CL, Duell EA. Cyclic AMP, cyclic GMP and glucocorticoids as potential metabolic regulators of epidermal proliferation and differentiation. J Invest Dermatol 1975; 65: 179-190.
56. Bloomfield FJ, Young Mm. Enhanced release of inflammatory mediators from lithium-stimulated neutrophils in psoriasis. Br J Dermatol 1983; 109: 9-13.
57. Grisaru N, Belmaker RH. Lithium dosage and inositol levels. Br J Psychiatry 1994; 164: 133-134.
58. Allan SJ, Kavanagh GM, Herd RM, et al. The effect of inositol supplements on the psoriasis of the patients taking lithium: A randomized placebo-controlled trial. Br J Dermatol 2004; 150: 966-969.
59. Ockenfels HM, Wagner SN, Keim-Maas C, et al. Lithium and psoriasis: cytokine modulation of cultured lymphocytes and psoriatic keratinocytes by lithium. Arch Dermatol Res 1996; 288: 173-178.
60. Kniff EM, Kupka RW, Ruwhof C. Evidence that immunopathogenic mechanism of lithium-induced psoriasis differs from that of regular psoriasis. Bipolar Disord 2005; 7: 388-389.
61. 3) on in-vitro cultured normal human skin explants. J Eur Acad Dermatol Venereol 2000; 14: 97-99.
62. Al'Abadie MS, Kent CG, Gawkrodger DJ. The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol 1994; 130: 199-203.
63. Griffiths CE, Richards HL. Psychological influence in psoriasis. Clin Exp Dermatol 2001; 26: 338-342.
64. Alvarez WA, Freinhar JP. Direct evidence for a lithium-induced psoriasis syndrome. Int J Psychosom 1984; 31: 21-22.
65. Selmanowitz VJ. Lithium, leukocytes and lesions. Clin Dermatol 1986; 4: 170-175.
66. Akkerhuis GW, Nolen WA. Lithium-associated psoriasis and omega-3 fatty acids. Am J Psychiatry 2003; 160: 1355.
67. Watchter T, Murach WM, Brocker EB, et al. Recalcitrant lithium-induced psoriasis in a suicidal patient alleviated by tumor necrosis factor-α inhibition. Br J Dermatol 2007; 157: 627-629.
68. McCreadie RG, Morrison DP. The impact of lithium in south west Scotland: demographic and clinical findings. Br J Psychiatry 1985; 146: 70-74.
69. Yassa R, Ananth J. Hair loss in the course of lithium treatment: A report of two cases. Can J Psychiatry 1983; 28: 132-133.
70. Mortimer PS, Dawber RPR. Hair loss and lithium. Int J Dermatol 1984; 23: 603-604.
71. Ghadirian AM, Lalinec-Michaud M. Report of a patient with lithium-related alopecia and psoriasis. J Clin Psychiatry 1986; 47: 212-213.
72. Muniz CE, Salem RB, Director KL. Hair loss in a patient receiving lithium. Psychosomatics 1982; 23: 312-313.
73. Wagner KD, Teicher MH. Lithium and hair loss in childhood. Psychosomatics 1991; 32: 355-356.
74. Silvestri A, Santonastaso P, Paggiarin D. Alopecia areata during lithium therapy. Gen Hosp Psychiatry 1988; 10: 46-48.
75. Warnock JK. Psychotropic medication and drug-related alopecia. Psychosomatics 1991; 32: 149-152.
76. McCreadie RG, Farmer JG. Lithium and hair texture. Acta Psychiatr Scand 1985; 72: 387-388.
77. McKenney PA, Finkenbine RD, DeVane CL. Alopecia and mood stabilizer therapy. Ann Clin Psychiatry 1996; 8: 183-185.
78. Mercke Y, Sheng H, Khan T, et al. Hair loss in psychopharmacology. Ann Clin Psychiatry 2000; 12: 35-42.
79. Valeyrie-Allanore L, Sassolas B, Roujeau JC. Drug-induced skin, nail and hair disorders. Drug Saf 2007; 30: 1011-1030.
80. Dawber R, Mortimer P. Hair loss during lithium treatment. Br J Dermatol 1982; 107: 124-125.
81. Shader RI. Can lithium cause hair loss? J Clin Psychopharmacol 1983; 3: 122-123.
82. Katsarou-Katsari A, Singh LK, Theoharides TC. Alopecia areata and affected skin CRH receptor upregulation induced by acute emotional stress. Dermatology 2001; 203: 157-161.
83. Toyoda M, Makino T, Kagoura M, et al. Expression of neuropeptide-degrading enzymes in alopecia areata: An immunohistochemical study. Br J Dermatol 2001; 144: 46-54.
84. Denicoff KD, Lehman ZA, Rubinow DR, et al. Suicidal ideation in Darier's disease. J Am Acad Dermatol 1990; 22: 196-198.
85. Burge SM, Wilkinson JD. Darier-White disease: A review of the clinical features in 163 patients. J Am Acad Dermatol 1992; 27: 40-50.
86. Wang SL, Yang SF, Chen CC, et al. Darier's disease associated with bipolar affective disorder: A case report. Kaohsiung J Med Sci 2002; 18: 622-626.
87. Ehrt U, Brieger P. Comorbidity of keratosis follicularis (Darier's disease) and bipolar affective disorder. An indication for valproate instead of lithium. Gen Hosp Psychiatry 2000; 22: 128-129.
88. Milton GP, Peck GL, Fu JJ, et al. Exacerbation of Darier's disease by lithium carbonate. J Am Acad Dermatol 1990; 23: 926-928.
89. Clark RD Jr, Hammer CJ, Patterson SD. A cutaneous disorder (Darier's disease) evidently exacerbated by lithium carbonate. Psychosomatics 1986; 27: 800-801.
90. Sule N, Teszas A, Kalman E, et al. Lithium suppresses epidermal SERCA2 and PMR1 levels in the rat. Pathol Oncol Res 2006; 12: 234-236.
91. Rubin MB. Lithium-induced Darier's disease. J Am Acad Dermatol 1995; 32: 674-675.
92. Chen GY, Chen YH, Hsu MM, et al. Onychomadesis and onycholysis associated with capacitabine. Br J Dermatol 2001; 145: 521-523.
93. Buka R, Hille R, McCormack P. Yellow nail pigmentation following depakote therapy. J Drugs Dermatol 2003; 2: 545-547.
94. Sharma A, Padda PR. Lithium-induced rash. Prim Care Companion J Clin Psychiatry 2006; 8: 377.
95. Lambert D, Beer F, Gisselman R, et al. Cutaneous lesions due to lithium therapy. Ann Dermatol Venereol 1982; 109: 19-24.
96. Meinhold JM, West DP, Gurwich E. Cutaneous reactions to lithium carbonate: A case report. J Clin Psychiatry 1980; 41: 395-396.
97. Rifkin A, Kurtin SB, Quitkin F, et al. Lithium-induced folliculitis. Am J Psychiatry 1973; 130: 1018-1019.
98. Dunner DL. Optimizing lithium treatment. J Clin Psychiatry 2006; 61(Suppl. 9): 76-81.
99. Marinella MA. Lithium therapy associated with hidradenitis suppurativa. Acta Derm Venereol 1997; 77: 483.
100. Gupta AK, Knowles SR, Gupta MA, et al. Lithium therapy associated with hidradenitis suppurativa: Case report and a review of the dermatologic side effects of lithium. J Am Acad Dermatol 1995; 32: 382-386.
101. Aithal V, Appaih P. Lithium induced hidradenitis suppurativa and acne conglobata. Indian J Dermatol Venereol Leprol 2004; 70: 307-309.
102. Campisi G, Florena AM, Franco V, et al. Oral lichenoid drug reaction by lithium in a patient with bipolar disorder. J Oral Pathol Med 2005; 34: 124-126.
103. Menni S, Barbareschi M, Fargetti G, et al. Lichenoid eruptions of mouth mucosa induced by lithium carbonate. 2 cases. Ann Dermatol Venereol 1995; 122: 91-93.
104. Bone S, Roose SP, Dunner DL, et al. Incidence of side effects in patients on long-term lithium therapy. Am J Psychiatry 1980; 137: 103-104.
105. Hogan DJ, Murphy MD, Burgess WR, et al. Lichenoid stomatitis associated with lithium carbonate. J Am Acad Dermatol 1985; 13: 243-246.
106. Bar Nathan EA, Brenner S, Horowitz I. Nonspecific stomatitis due to lithium therapy. Am J Psychiatry 1985; 142: 1126.
107. Nathan KI. Development of mucosal ulceration with lithium carbonate therapy. Am J Psychiatry 1995; 152: 956-957.
108. Clark DB. Dental care for the patient with bipolar disorders. J Can Dent Assoc 2003; 69: 20-24.
109. Patki AH. Geographic tongue developing in a patient on lithium carbonate therapy (letter). Int J Dermatol 1992; 31: 368-369.
110. Muniz CE, Berghman DH. Contact stomatitis and lithium carbonate tablets. J Am Med Assoc 1978; 239: 2759.
111. Madinier I, Berry N, Chichmanian RM. Drug-induced oral ulcerations. Ann Med Interne (Paris) 2000; 151: 248-254.
112. Firth NA, Reade PC. Comparison of eosinophil densities in oral mucosal lichen planus and lichenoid drug reactions. J Oral Pathol Med 1990; 19: 86-88.
113. O'Keefe E, Braverman IM, Cohen I. Annulus migrans: Identical lesions in pustular psoriasis, Reiter's syndrome, and geographical tongue. Arch Dermatol 1973; 107: 240-244.
114. Srebrink A, Bar-Nathan EA, Ilie B, et al. Vaginal ulcerations due to lithium carbonate therapy. Cutis 1991; 48: 65-66.
115. Webster GF. Pustular drug reactions. Clin Dermatol 1993; 11: 541-543.
116. McWhirter JD, Hashimoto K, Fayne S, et al. Linear IgA bullous dermatosis related to lithium carbonate. Arch Dermatol 1987; 123: 1120-1122.
117. Sterling GB, De Pietro WP. Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) associated with lithium carbonate therapy. Cutis 1988; 41: 165-166.
118. Lieb J. Remission of recurrent herpes infection during therapy with lithium. N Engl J Med 1979; 301: 942.
119. Skinner GRB, Hartley C, Buchan A, et al. The effect of lithium chloride on the replication of herpes simplex virus. Med Microbiol Immunol (Berl) 1980; 168: 139-148.
120. Shader R. Lithium in herpes simplex. Lancet 1983; 2: 516.
121. Amsterdam JD, Maislin G, Rybakowsky J. A possible antiviral action of lithium carbonate in herpes simplex virus infections. Biol Psychiatry 1990; 27: 447-453.
122. Cernescu C, Popescu L, Constantinescu S, et al. Antiviral effect of lithium chloride. Virologie 1998; 39: 93-101.
123. Sparsa A, Bonnetblanc JM. Lithium. Ann Dermatol Venereol 2004; 131: 255-261.
124. Amsterdam JD, Maislin G, Hooper MB. Suppression of herpes simplex virus infection with oral lithium carbonate - a possible antiviral activity. Pharmacotherapy 1996; 16: 1070-1075.
125. Amsterdam JD, Maislin G, Potter L, et al. Reduced rate of recurrent genital herpes infections with lithium carbonate. Psychopharmacol Bull 1990; 26: 343-347.
126. Ward KA, Armstrong KD, Maw RD, et al. A pilot study to investigate the treatment of anogenital warts with topical lithium succinate cream (8% lithium succinate, 0.05% zinc sulphate). Int J STD AIDS 1997; 8: 515-517.
127. Sylvester RK, Leitch J, Granum C. Does acyclovir increase serum lithium levels? Pharmacotherapy 1996; 16: 466-468.
128. Kuhnley EJ, Granoff AL. Exfoliative dermatitis during lithium treatment. Am J Psychiatry 1979; 136: 1340-1341.
129. Akhyani M, Ghodsi ZS, Toosi S, et al. Erythroderma: A clinical study of 97 cases. BMC Dermatol 2005; 5: 5.
130. Yeung CK, Chan HHL. Cutaneous adverse effects of lithium. Am J Clin Dermatol 2004; 5: 3-8.
131. Lambert D, Beylot C, Mazet J, et al. Drug eruptions caused by lithium salts. Ann Med Interne (Paris) 1984; 135: 637-638.
132. Fearfield LA, Bunker CB. Pityriasis versicolor associated with oral lithium therapy. Clin Exp Dermatol 1997; 22: 57-59.
133. Christodoulou G, Georgala S, Vareltzides A, et al. Lithium in seborrheic dermatitis. Psychiatr J Univ Ott 1983; 8: 27-29.
134. Leeming JP, Burton JL. Lithium succinate and seborrheic dermatitis: An antifungal mode of action? Br J Dermatol 1990; 122: 718-719.
135. Horrobin DF. Lithium, fatty acids and seborrheic dermatitis: A new mechanism of lithium action and a new treatment for seborrheic dermatitis. Lithium 1990; 1: 149-155.
136. Nenoff P, Haustein UF, Munzburger C. In vitro activity of lithium succinate against Malassezia furfur. Dermatology 1995; 190: 48-50.
137. Horrobin DF. Effects of lithium on essential fatty acid and prostaglandin metabolism. In: Bach RO, Gallicchio VS, eds. Lithium and Cell Physiology. New York: Springer-Verlag, 1990: 137-149.
138. Dreno B, Chosidow O, Revuz J, et al. Lithium gluconate 8% vs. ketoconazole 2% in the treatment of seborrheic dermatitis: A multicenter, randomized study. Br J Dermatol 2003; 148: 1230-1236.
139. Dreno B, Moyse D. Lithium gluconate in the treatment of seborrheic dermatitis: A multicenter, randomized, double blind study versus placebo. Eur J Dermatol 2002; 12: 549-552.
140. Efalith Multicenter Trial Group. A double-blind, placebo-controlled, multicenter trial of lithium succinate ointment in the treatment of seborrheic dermatitis. J Am Acad Dermatol 1992; 26: 452-457.
141. Langtry JAA, Rowland Payne CME, Staughton RDC, et al. Topical lithium succinate ointment (Efalith) in the treatment of AIDS-related seborrheic dermatitis. Clin Exp Dermatol 1997; 22: 216-219.
142. Cuelenaere C, De Bersaques J, Kint A. Use of topical lithium succinate in the treatment of seborrheic dermatitis. Dermatology 1992; 184: 194-197.
143. Dreno B, Blouin E, Moyse D. Lithium gluconate 8% in the treatment of seborrheic dermatitis. Ann Dermatol Venereol 2007; 134: 347-351.
144. Warnock JK, Morris DW. Adverse cutaneous reactions to mood stabilizers. Am J Clin Dermatol 2003; 4: 21-30.
145. Hoxtell E, Dahl MV. Xerosis from lithium carbonate [letter]. Arch Dermatol 1975; 111: 1073-1074.
146. Kurtin SB. Lithium carbonate dermatitis. J Am Med Assoc 1973; 223: 802.
147. Ruiz-Maldonado R, Perez de Francisco C, Tamayo L. Lithium dermatitis. J Am Med Assoc 1973; 224: 1534.
148. Posey RE. Lithium carbonate dermatitis. J Am Med Assoc 1972; 221: 1517.
149. Shukla S, Mukherjee S. Lichen simplex chronicus during lithium treatment. Am J Psychiatry 1984; 141: 909-910.
150. Frenk E. Inflammatory verrucous hyperplasia of the skin: An unusual side effect of long term lithium therapy. Arch Dermatol Res 1981; 270: 226.
151. White SW. Lithium and warts. Int J Dermatol 1982; 21: 107.
152. Wakelin SH, Lipscombe T, Orton DI. Lithium-induced follicular hyperkeratosis. Clin Exp Dermatol 1996; 21: 296-298.
153. Shukla VR, Borison RL. Lithium and lupus like syndrome. J Am Med Assoc 1982; 248: 921-922.
154. Presley AP, Kahn A, Williamson N. Antinuclear antibodies in patients on lithium carbonate. Br Med J 1976; 2: 280-281.
155. Kimyai-Asadi A, Harris JC, Nousari HC. Critical overview: Adverse cutaneous reactions to psychotropic medications. J Clin Psychiatry 1999; 60: 714-725.
156. Balldin J, Berggren U, Heijer A, et al. Erythema multiforme caused by lithium. J Am Acad Dermatol 1991; 24: 1015-1016.
157. Singh T, Chavan BS. Pitting type pedal edema with lithium: A case report. German J Psychiatry 2008; 11: 76-78.
158. Luby ED, Schwartz D, Rosenbaum H. Lithium carbonate-induced myxedema. J Am Med Assoc 1971; 218: 1298-1299.
159. Leung AKC. Port wine stain associated with maternal use of lithium carbonate. J Natl Med Assoc 1987; 79: 877-878.
160. Francis GJ, Silverman AR, Saleh O, et al. Follicular mycosis fungoides associated with lithium. J Am Acad Dermatol 2001; 44: 308-309.